[1]
Parra, G.A., Lindarte, H.H. and Rubio, A.F. 2020. Over optimum response to PCSK-9 inhibitors: ¿is it mandatory to supply them every 2 weeks?, about a case. Revista Colombiana de Endocrinología, Diabetes & Metabolismo. 7, 1 (Apr. 2020), 43–44. DOI:https://doi.org/10.53853/encr.7.1.568.